Hertig said some patients require compounded medications due to a drug shortage or if a patient has an allergy to an ingredient in the FDA-approved drug
Detailed Product Description 5-Amino-1-Methylquinolinium (5-Amino-1MQ) is a first-in-class, selective NNMT inhibitor designed for research into metabolic regulation, obesity, diabetes, nonalcoholic fatty liver disease, and age-associated muscle degeneration
Muscle-bone interactions are crucial during movement and weight-bearing activities, where tensile and compressive forces are transmitted via tendons onto cortical and trabecular bone
*Prescription products require an online consultation with a healthcare professional who will determine if a prescription is appropriate
Swisher SG , Economou JS, Shau H, Holmes EC, Golub SH
It increases the shelf life of the reconstituted solution, lowers the possibility of contamination between uses and lets researchers stay with a single protocol across different readings